Lawrence J. Ellison Ambulatory Care Center
4860 Y St., Suite 0101
Sacramento, CA 95817
VA Northern CA Health Care System
10535 Hospital Way
Mather, CA 95655
Additional Phone Numbers
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
Philosophy of Care
In a time of ever-increasing use of technology in healthcare, infectious diseases requires more than diagnostic testing and procedures. The practice of Infectious Diseases requires detailed discussions with patients and time spent understanding the course of their disease processes.
Dr. Maniar’s clinical work includes the spectrum of infectious diseases from HIV and hepatitis C to infections in travelers and hospital-acquired infections. She sees patients in the ambulatory care and inpatient settings.
In addition to her clinical role, Dr. Maniar is head of Infection Control at VA Northern California Healthcare System. She participates in antimicrobial stewardship program to encourage the appropriate use of antibacterials.
M.D., UC Davis School of Medicine, Sacramento CA 2000
B.A./B.S., UCLA, Los Angeles CA 1996
Internal Medicine, UC Davis Medical Center, Sacramento CA 2000-2003
Infectious Diseases, UC Davis Medical Center, Sacramento CA 2003-2005
American Board of Internal Medicine, 2003
American Board of Internal Medicine, Infectious Disease, 2006
Infectious Disease Society of America
Select Recent Publications
Sharon VR, Kim J, Sudhakar S, Fung MA, Maniar A. Disseminated cutaneous sporotrichosis. Lancet Infect Dis. 2013 Jan;13(1):95.
Ludwig A, Sato K, Schirmer P, Maniar A, Lucero-Obusan C, Fleming C, Ryono R, Oda G, Winters M, Holodniy M. Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-term-care facility. Epidemiol Infect. 2013 Feb 22:1-6.
Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J. HIV infection and atherosclerosis: beyond traditional risk factors. Eur J Prev Cardiol 2013 Oct;(20):720-728.
Ellis CL, Ma Z-M, Maniar AH, Mann SK, Overman HA, Li CS, Yotter T, Knight TH, Miller CJ, Pollard RB, Rutledge JC, Asmuth DM. Application of 16S ribosomal RNA gene-targeted pyrosequencing to investigate the consequence of HIV-disease and antiviral therapy on the gut microbiome: a microbial (meta)genomic snapshot of duodenal biopsies, luminal aspirates, and stool pre- and post-treatment. Antiviral Therapy 2011; 16 Suppl 2
Ellis CL, Ma ZM, Mann SK, Li CS, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM. Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations with Immune Activation. J Acquir Immune Defic Syndr 2011 March 23; epub.